piracetam has been researched along with Infections, Plasmodium in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Excerpt | Relevance | Reference |
---|---|---|
" Since Piracetam (2-oxo-1 pyrrolidine acetamide) has been shown to have a number of clinically beneficial actions on the formed elements of the blood including disengagement of adherent diabetic and sickle erythrocytes there is a rational basis for the trial of Piracetam as an adjuvant drug in SS disease and in diabetes mellitus to improve function of the microcirculation." | 7.66 | Erythrocyte - endothelial cell adherence in sickle cell disease, diabetes mellitus, and falciparum malaria: adverse effects reversed with piracetam. ( Burek, L; Collier, BD; Diglio, CA; Fleischman, JA; Henry, RL; Nalbandian, RM; O'Donnell, FE; Reeser, FH; Williams, G, 1982) |
" Since Piracetam (2-oxo-1 pyrrolidine acetamide) has been shown to have a number of clinically beneficial actions on the formed elements of the blood including disengagement of adherent diabetic and sickle erythrocytes there is a rational basis for the trial of Piracetam as an adjuvant drug in SS disease and in diabetes mellitus to improve function of the microcirculation." | 3.66 | Erythrocyte - endothelial cell adherence in sickle cell disease, diabetes mellitus, and falciparum malaria: adverse effects reversed with piracetam. ( Burek, L; Collier, BD; Diglio, CA; Fleischman, JA; Henry, RL; Nalbandian, RM; O'Donnell, FE; Reeser, FH; Williams, G, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nalbandian, RM | 1 |
Henry, RL | 1 |
Fleischman, JA | 1 |
Burek, L | 1 |
Williams, G | 1 |
O'Donnell, FE | 1 |
Diglio, CA | 1 |
Collier, BD | 1 |
Reeser, FH | 1 |
1 other study available for piracetam and Infections, Plasmodium
Article | Year |
---|---|
Erythrocyte - endothelial cell adherence in sickle cell disease, diabetes mellitus, and falciparum malaria: adverse effects reversed with piracetam.
Topics: Anemia, Sickle Cell; Cell Adhesion; Diabetes Mellitus; Endothelium; Erythrocytes; Humans; Malaria; P | 1982 |